Bank of America
IDIX

Bank of America’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bank of America’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,100
Closed -$51K – 8476
2014
Q2 		$51K Buy
2,100
+1,200
+133% +$12.5K ﹤0.01% 6646
2014
Q1 		$5K Buy
900
+600
+200% +$4.18K ﹤0.01% 7389
2013
Q4 		$2K Sell
300
-900
-75% -$4.16K ﹤0.01% 7687
2013
Q3 		$6K Sell
1,200
-88,800
-99% -$389K ﹤0.01% 7358
2013
Q2 		$325K Buy
+90,000
New +$368K ﹤0.01% 5158

Bank of America's IDIX Position: Q3 2014 in Review

Bank of America sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 9,139 shares — an estimated $221K sold.

Bank of America first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $3.06M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Bank of America reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Bank of America sold 9,139 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $221K.
  • Bank of America first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Bank of America's IDENIX PHARMACEUTICALS INC position peaked at $3.06M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Bank of America's 13F filing for Q3 2014, filed 14 Nov 2014.